Charles J. Lockwood, MD, MHCM

About Charles J. Lockwood, MD, MHCM

Dr. Charles Lockwood is Executive Vice President and Chief Academic Officer at Tampa General Hospital (TGH), the Executive Vice President of USF Health, and Dean of the USF Health Morsani College of Medicine (MCOM). He is a Professor of Obstetrics & Gynecology and Public Health.

As EVP of USF Health, he oversees the University of South Florida's colleges of medicine, nursing, pharmacy, and public health as well the schools of Physical Therapy & Rehabilitation Sciences and Graduate Studies. As MCOM Dean, he is responsible for the medical school's educational and research operations, and additionally leads the 900-provider faculty group practice. Since 2014, Dr. Lockwood has overseen a transformation of USF Health, dramatically increasing NIH Awards, and patient safety, satisfaction, and outcomes as well as greatly enhancing student competitiveness and academic performance, lifting the medical school's ranking on the U.S. News & World Report from 80 to 48 out of 154 allopathic medical schools. In addition, he helped obtain approval and funding to opening the new USF Health Morsani College of Medicine and Heart Institute in Water Street with the support of TGH. Working with TGH CEO John Couris, he has strengthened the affiliation between USF Health and TGH through a substantial integration of clinical services.

As a clinician, Dr. Lockwood has delivered over 5,000 infants, cared for large numbers of medically complicated pregnancies, and been named to national and regional "Best Doctors" lists annually since 1995. He serves on the Florida Medical Association (FMA) Board of Governors, on the Executive Committee of the FMA political action committee, and on the Executive Committee of the Hillsborough County Medical Association. He has served on or chaired multiple committees of the American College of Obstetricians and Gynecologists (ACOG) and receive ACOG's Public Service Award for his "enduring commitment to women's health."

Dr. Lockwood's research has been supported by multiple NIH and March of Dimes grants. He is credited with leading the research team that discovered the first predictive test for preterm birth — fetal fibronectin. He has chaired and/or served on multiple NIH study sections and FDA committees, authored more than 300 peer-reviewed publications, and another 300 invited papers, textbook chapters and editorials. He has also authored or co-authored five monographs and co-edited seven major textbooks, three with multiple editions. He is the Obstetrics Section editor for UpToDate and was the Editor-in-Chief of Contemporary Ob/Gyn for 20 years, where his editorials garnered six national publishing awards.

Dr. Lockwood is past president of the Society for Reproductive Investigation (SRI) and the American Gynecological and Obstetrical Society. His research has led to multiple awards including the SRI's Distinguished Scientist Award, the Society for Maternal-Fetal Medicine's Lifetime Achievement Award, and the NICHD-Frontiers in Reproduction Beacon award. Dr. Lockwood is an elected member of the Sigma Xi and Alpha Omega Alpha honor societies, the American Association for the Advancement of Science (AAAS) and the National Academy of Medicine (formerly the Institute of Medicine).

Previously, Dr. Lockwood was Dean at The Ohio State University College of Medicine and chaired Ob/Gyn departments at Yale and New York University. At the former institution, he chaired the Yale Medical Group Board of Governors and at the latter institution, he served as interim director of the Kaplan NCI-designated Cancer Center. He graduated magna cum laude from Brown University, received his M.D. from the University of Pennsylvania and a Master's in Healthcare Management from the Harvard School of Public Health. He served his Ob/Gyn residency at Pennsylvania Hospital, a Maternal-Fetal Medicine fellowship at Yale and a post-doctoral research fellowship at Mt. Sinai School of Medicine in NYC.